MGX Stock Summary and Trading Ideas (Metagenomi Therapeutics | NASDAQ:MGX)

Metagenomi Therapeutics Inc formerly, Metagenomi Inc is a genetic medicines company committed to developing curative therapeutics for patients using its proprietary, comprehensive metagenomics-derived genome editing toolbox. The genome editing toolbox includes systems for making small edits such as programmable nucleases, base editors, small RNA-mediated integration systems (RIGS), as well as large gene integration systems including large template RIGS and CRISPR-associated transposases (CASTs). The company is focused on its vivo gene editing for its wholly-owned pipeline while pursuing technology out licensing for ex vivo cell therapy. Its pipeline includes product candidates aimed at addressing disorders like Hemophilia A, Refractory Hypertension, Cardiovascular diseases, and others.

Metagenomi Therapeutics trades on the NASDAQ stock market under the symbol MGX.

As of February 6, 2026, MGX stock price climbed to $1.54 with 440,117 million shares trading.

MGX has a beta of 1.44, meaning it tends to be more sensitive to market movements. MGX has a correlation of 0.10 to the broad based SPY ETF.

MGX has a market cap of $57.80 million. This is considered a Micro Cap stock.

Last quarter Metagenomi Therapeutics reported $9 million in Revenue and -$.55 earnings per share. This beat revenue expectation by $203,000 and exceeded earnings estimates by $.01.

The top ETF exchange traded funds that MGX belongs to (by Net Assets): VTI, VXF, IWC, AVSC.

MGX has underperformed the market in the last year with a price return of -41.7% while the SPY ETF gained +15.1%. MGX has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -30.6% and -8.9%, respectively, while the SPY returned +3.3% and +0.2%, respectively.

MGX support price is $1.36 and resistance is $1.46 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that MGX shares will trade within this expected range on the day.